Morgan Stanley lowered the firm’s price target on Ryan Specialty (RYAN) to $65 from $68 and keeps an Overweight rating on the shares. The firm said that, broadly speaking, commercial property and casualty continues to face growth headwinds from the commercial property pricing slowdown in both primary and reinsurance sub-sectors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- 3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
- Ryan Specialty upgraded to Overweight from Equal Weight at Wells Fargo
- Wolfe Research launches coverage with positive view on Life Insurance names
- Ryan Specialty assumed with Outperform from Peer Perform at Wolfe Research
- Ryan Specialty Group Appoints Michael Bungert to Board